| 000 | 01655 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250513183324.0 | ||
| 264 | 0 | _c19990819 | |
| 008 | 199908s 0 0 eng d | ||
| 022 | _a0960-894X | ||
| 024 | 7 |
_a10.1016/s0960-894x(99)00181-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWilliams, P D | |
| 245 | 0 | 0 |
_aNonpeptide oxytocin antagonists: analogs of L-371,257 with improved potency. _h[electronic resource] |
| 260 |
_bBioorganic & medicinal chemistry letters _cMay 1999 |
||
| 300 |
_a1311-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBenzoxazines |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInhibitory Concentration 50 |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 |
_aOxazines _xchemical synthesis |
| 650 | 0 | 4 |
_aOxytocin _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPiperidines _xchemical synthesis |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 700 | 1 | _aBock, M G | |
| 700 | 1 | _aEvans, B E | |
| 700 | 1 | _aFreidinger, R M | |
| 700 | 1 | _aGallicchio, S N | |
| 700 | 1 | _aGuidotti, M T | |
| 700 | 1 | _aJacobson, M A | |
| 700 | 1 | _aKuo, M S | |
| 700 | 1 | _aLevy, M R | |
| 700 | 1 | _aLis, E V | |
| 700 | 1 | _aMichelson, S R | |
| 700 | 1 | _aPawluczyk, J M | |
| 700 | 1 | _aPerlow, D S | |
| 700 | 1 | _aPettibone, D J | |
| 700 | 1 | _aQuigley, A G | |
| 700 | 1 | _aReiss, D R | |
| 700 | 1 | _aSalvatore, C | |
| 700 | 1 | _aStauffer, K J | |
| 700 | 1 | _aWoyden, C J | |
| 773 | 0 |
_tBioorganic & medicinal chemistry letters _gvol. 9 _gno. 9 _gp. 1311-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0960-894x(99)00181-x _zAvailable from publisher's website |
| 999 |
_c10299310 _d10299310 |
||